These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1109 related items for PubMed ID: 25112661

  • 1. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
    Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Jüni P.
    Eur Heart J; 2015 Jan 07; 36(2):120-8. PubMed ID: 25112661
    [Abstract] [Full Text] [Related]

  • 2. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L, CLOSURE I Investigators.
    JACC Cardiovasc Interv; 2014 Aug 07; 7(8):913-20. PubMed ID: 25147037
    [Abstract] [Full Text] [Related]

  • 3. The Closure of Patent Foramen Ovale in Preventing Subsequent Neurological Events: A Bayesian Network Meta-Analysis to Identify the Best Device.
    Varotto L, Bregolin G, Paccanaro M, De Boni A, Bonanno C, Perini F.
    Cerebrovasc Dis; 2020 Aug 07; 49(2):124-134. PubMed ID: 32289794
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials.
    Kwong JS, Lam YY, Yu CM.
    Int J Cardiol; 2013 Oct 09; 168(4):4132-8. PubMed ID: 23890879
    [Abstract] [Full Text] [Related]

  • 8. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
    Fortuni F, Crimi G, Leonardi S, Angelini F, Raisaro A, Lanzarini LF, Oltrona Visconti L, Ferrario M, De Ferrari GM.
    J Cardiovasc Med (Hagerstown); 2018 Jul 09; 19(7):373-381. PubMed ID: 29708911
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
    Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.
    JACC Cardiovasc Interv; 2013 Dec 09; 6(12):1316-23. PubMed ID: 24139929
    [Abstract] [Full Text] [Related]

  • 12. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, PC Trial Investigators.
    N Engl J Med; 2013 Mar 21; 368(12):1083-91. PubMed ID: 23514285
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
    Wiktor DM, Carroll JD.
    Circ Cardiovasc Interv; 2018 Mar 21; 11(3):e004152. PubMed ID: 29870380
    [Abstract] [Full Text] [Related]

  • 16. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
    Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.
    Eur Heart J; 2013 Nov 21; 34(43):3342-52. PubMed ID: 23847132
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous closure versus medical therapy for stroke with patent foramen Ovale: a systematic review and meta-analysis.
    Zhang XL, Kang LN, Wang L, Xu B.
    BMC Cardiovasc Disord; 2018 Mar 02; 18(1):45. PubMed ID: 29499641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patent Foramen Ovale Closure Versus Medical Therapy in Cryptogenic Strokes and Transient Ischemic Attacks: A Meta-Analysis of Randomized Trials.
    Vidale S, Russo F, Campana C, Agostoni E.
    Angiology; 2019 Apr 02; 70(4):325-331. PubMed ID: 30270651
    [Abstract] [Full Text] [Related]

  • 20. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
    Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, Sommer RJ, Beohar N.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):968-75. PubMed ID: 23832613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.